Biotech Jason Mast and Matthew Herper STAT Plus: As Ginkgo stock sinks, CEO Jason Kelly tries to win over drugmakers in San Francisco
Biotech Matthew Herper STAT Plus: Former Merck CEO: Democracy and the drug industry are both in danger
Biotech Scott Kirsner — Boston Globe STAT Plus: This billionaire has quietly driven Boston’s biotech industry for decades
Pharma Jessica Davis Plüss STAT Plus: European researchers seek greater stake in drug development in bid to improve access
Biotech Matthew Herper STAT Plus: Bristol Myers Squibb to buy Turning Point Therapeutics for $4.1 billion to gain drugs targeting rare cancer mutations
Biotech Matthew Herper and Megan Molteni STAT Plus: Bayer to pay CRISPR-focused Mammoth Biosciences $40 million for gene editing research
Politics Rachel Cohrs STAT Plus: The four senators who could make or break Democrats’ drug pricing ambitions